Manus Bio
holds patented technology (filed and granted 2024-2026) for producing oxygenated sesquiterpenes such as nootkatone and nootkatol from valencene using engineered cytochrome P450 and SrKO-class oxidase enzymes expressed in bacterial or yeast host cells.
- Country
- United States
oxygenated-terpenoids
us
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | — | ✓ | ✓ | ✓ |
| platform-chemicals | ✓ | ✓ | — | ✓ |
Regulatorsfdaefsareach
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Rare sugars and enzymatic sweeteners | food-alt-protein | Low | → |
| Terpenes & terpenoids as platform molecules | platform-chemicals | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.